⌘K

Home/Filings/4/0000950170-25-054740

4//SEC Filing

Bellete Ambaw 4

Accession 0000950170-25-054740

CIK 0001991792other

View on SEC.gov Company Profile

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 4:15 PM ET

Size

5.4 KB

Accession

0000950170-25-054740

Insider Transaction Report

Form 4

Period: 2025-04-15

CG Oncology, Inc.CGON

President and COO

Transactions

Award
Employee Stock Option (Right to Buy)
2025-04-15+284,816→ 284,816 total
Exercise: $20.11Exp: 2035-04-14→ Common Stock (284,816 underlying)

Footnotes (1)

[F1]1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

CG Oncology, Inc.

CIK 0001991792

Entity typeother

Related Parties

1

filerCIK 0002007090

Filing Metadata

Form type: 4
Filed: Apr 15, 8:00 PM ET
Accepted: Apr 16, 4:15 PM ET
Size: 5.4 KB

View on SEC.gov